• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

药物相互作用导致的无意磺脲类药物中毒:一例报告

Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report.

作者信息

Gunaratne Keith, Austin Emily, Wu Peter E

机构信息

Department of Medicine, University of Toronto, Toronto, ON, Canada.

Division of Emergency Medicine, University of Toronto, Toronto, ON, Canada.

出版信息

BMC Res Notes. 2018 May 21;11(1):331. doi: 10.1186/s13104-018-3404-8.

DOI:10.1186/s13104-018-3404-8
PMID:29784014
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5963053/
Abstract

BACKGROUND

Sulfonylureas are widely used for type 2 diabetes mellitus, but these medications carry a risk of hypoglycemia. Drug-drug interactions that inhibit sulfonylurea metabolism and thus increase systemic exposure can cause unintentional sulfonylurea toxicity.

CASE PRESENTATION

A 56-year-old man presented with severe, recurrent hypoglycemia. He had a history of type 2 diabetes mellitus and was taking the sulfonylurea gliclazide with no prior episodes of hypoglycemia. The onset of his hypoglycemia occurred within days after starting voriconazole and subsequently fluconazole for a fungal pneumonia. Unintentional sulfonylurea toxicity developed due to an adverse drug-drug interaction between gliclazide and these antifungals. Azole antifungals inhibit the metabolism of sulfonylureas resulting in increased systemic exposure and consequent toxicity. After the diagnosis of sulfonylurea toxicity was recognized, the patient was treated initially with dextrose and then administered octreotide to prevent recurrent hypoglycemia. He was successfully managed, his hypoglycemic episodes resolved, and his medications were adjusted to avoid any further adverse interactions.

CONCLUSIONS

Adverse drug-drug interactions continue to pose challenges to clinicians. Both individual vigilance and system wide strategies are needed to prevent and mitigate consequences. This case highlights an important drug-drug interaction and reviews the presentation, management and antidotal therapy of sulfonylurea toxicity.

摘要

背景

磺脲类药物广泛用于2型糖尿病的治疗,但这些药物存在低血糖风险。抑制磺脲类药物代谢从而增加全身暴露量的药物相互作用可导致意外的磺脲类药物中毒。

病例报告

一名56岁男性出现严重的复发性低血糖。他有2型糖尿病病史,正在服用磺脲类药物格列齐特,之前没有发生过低血糖。在开始使用伏立康唑治疗真菌性肺炎,随后又使用氟康唑后,他在数天内出现了低血糖。由于格列齐特与这些抗真菌药物之间的不良药物相互作用,导致了意外的磺脲类药物中毒。唑类抗真菌药物抑制磺脲类药物的代谢,导致全身暴露量增加,进而产生毒性。在确诊为磺脲类药物中毒后,患者最初接受了葡萄糖治疗,然后使用了奥曲肽以预防复发性低血糖。他得到了成功的治疗,低血糖发作得到缓解,并且调整了用药以避免任何进一步的不良相互作用。

结论

不良药物相互作用继续给临床医生带来挑战。需要个人的警惕性和全系统的策略来预防和减轻后果。本病例突出了一种重要的药物相互作用,并回顾了磺脲类药物中毒的表现、管理和解毒治疗。

相似文献

1
Unintentional sulfonylurea toxicity due to a drug-drug interaction: a case report.药物相互作用导致的无意磺脲类药物中毒:一例报告
BMC Res Notes. 2018 May 21;11(1):331. doi: 10.1186/s13104-018-3404-8.
2
Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas.CYP2C9*3 等位基因的存在增加了接受磺酰脲类药物治疗的 2 型糖尿病患者发生低血糖的风险。
Pharmacogenomics. 2009 Nov;10(11):1781-7. doi: 10.2217/pgs.09.96.
3
Octreotide for the treatment of sulfonylurea poisoning.奥曲肽治疗磺酰脲类药物中毒。
Clin Toxicol (Phila). 2012 Nov;50(9):795-804. doi: 10.3109/15563650.2012.734626. Epub 2012 Oct 10.
4
Refractory Hypoglycemia Due to Sulfonylurea Contamination of Illicit Opioid Medications.因非法阿片类药物中磺酰脲类药物污染导致的难治性低血糖。
R I Med J (2013). 2024 May 2;107(5):11-13.
5
[Successful treatment of severe sulfonylurea-induced hypoglycemia by the subcutaneous administration of octreotide in an elderly patient with diabetes: A case report].[老年糖尿病患者皮下注射奥曲肽成功治疗严重磺脲类药物所致低血糖:一例报告]
Nihon Ronen Igakkai Zasshi. 2019;56(3):336-342. doi: 10.3143/geriatrics.56.336.
6
Octreotide: an antidote for sulfonylurea-induced hypoglycemia.奥曲肽:磺酰脲类药物所致低血糖的一种解药。
Ann Emerg Med. 2000 Aug;36(2):133-138. doi: 10.1067/mem.2000.108183.
7
Hypoglycemia in Frail Elderly Patients With Type 2 Diabetes Mellitus Treated With Sulfonylurea.使用磺脲类药物治疗的老年2型糖尿病虚弱患者的低血糖症
J Diabetes Sci Technol. 2017 Mar;11(2):438-439. doi: 10.1177/1932296816668873. Epub 2016 Sep 25.
8
Toxicology of oral antidiabetic medications.口服抗糖尿病药物的毒理学
Am J Health Syst Pharm. 2006 May 15;63(10):929-38. doi: 10.2146/ajhp050500.
9
Octreotide therapy for recurrent refractory hypoglycemia due to sulfonylurea in diabetes-related kidney failure.奥曲肽治疗糖尿病相关肾衰竭中磺脲类药物所致的复发性难治性低血糖症。
Endocr Pract. 2007 Jul-Aug;13(4):417-23. doi: 10.4158/EP.13.4.417.
10
Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.奥曲肽与标准治疗联合应用与单纯标准治疗在治疗磺脲类药物所致低血糖症方面的比较。
Ann Emerg Med. 2008 Apr;51(4):400-6. doi: 10.1016/j.annemergmed.2007.06.493. Epub 2007 Aug 30.

引用本文的文献

1
Variations in Octreotide Dosing in Published Reports of Sulfonylurea Toxicity: A Systematic Review, 1988-Present.1988年至今已发表的磺脲类药物毒性报告中奥曲肽剂量的变化:一项系统评价
J Med Toxicol. 2025 Apr;21(2):260-275. doi: 10.1007/s13181-024-01054-5. Epub 2025 Jan 16.
2
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients.二甲双胍、磺酰脲类和噻唑烷二酮类药物治疗 2 型糖尿病病例报告综述。
Med Sci (Basel). 2023 Aug 15;11(3):50. doi: 10.3390/medsci11030050.
3
Cardiovascular Risk after Kidney Transplantation: Causes and Current Approaches to a Relevant Burden.肾移植后的心血管风险:病因及应对相关负担的当前方法
J Pers Med. 2022 Jul 23;12(8):1200. doi: 10.3390/jpm12081200.
4
Clarithromycin and Glipizide Drug-drug Interaction Leading to Refractory Hypoglycemia.克拉霉素与格列吡嗪的药物相互作用导致难治性低血糖
Cureus. 2019 Jun 2;11(6):e4800. doi: 10.7759/cureus.4800.
5
Prevention of complications from use of conventional immunosuppressants: a critical review.常规免疫抑制剂使用相关并发症的预防:批判性综述。
J Nephrol. 2019 Dec;32(6):851-870. doi: 10.1007/s40620-019-00602-5. Epub 2019 Mar 29.

本文引用的文献

1
Adverse effects of voriconazole: Over a decade of use.伏立康唑的不良反应:十年应用情况
Clin Transplant. 2016 Nov;30(11):1377-1386. doi: 10.1111/ctr.12834. Epub 2016 Oct 14.
2
Clinically and pharmacologically relevant interactions of antidiabetic drugs.抗糖尿病药物的临床及药理学相关相互作用
Ther Adv Endocrinol Metab. 2016 Apr;7(2):69-83. doi: 10.1177/2042018816638050. Epub 2016 Mar 31.
3
Treatment of sulfonylurea and insulin overdose.磺脲类药物和胰岛素过量的治疗。
Br J Clin Pharmacol. 2016 Mar;81(3):496-504. doi: 10.1111/bcp.12822. Epub 2016 Jan 6.
4
CYP2C metabolism of oral antidiabetic drugs--impact on pharmacokinetics, drug interactions and pharmacogenetic aspects.CYP2C 代谢的口服降糖药物-对药代动力学、药物相互作用和药物遗传学方面的影响。
Expert Opin Drug Metab Toxicol. 2012 Dec;8(12):1549-63. doi: 10.1517/17425255.2012.722619.
5
Octreotide for the treatment of sulfonylurea poisoning.奥曲肽治疗磺酰脲类药物中毒。
Clin Toxicol (Phila). 2012 Nov;50(9):795-804. doi: 10.3109/15563650.2012.734626. Epub 2012 Oct 10.
6
Potential CYP2C9-mediated drug-drug interactions in hospitalized type 2 diabetes mellitus patients treated with the sulphonylureas glibenclamide, glimepiride or glipizide.住院 2 型糖尿病患者应用磺酰脲类药物(格列本脲、格列美脲或格列吡嗪)治疗时潜在的 CYP2C9 介导的药物相互作用。
J Intern Med. 2010 Oct;268(4):359-66. doi: 10.1111/j.1365-2796.2010.02257.x.
7
Comparison of octreotide and standard therapy versus standard therapy alone for the treatment of sulfonylurea-induced hypoglycemia.奥曲肽与标准疗法联合应用与单独使用标准疗法治疗磺脲类药物所致低血糖的比较。
Ann Emerg Med. 2008 Jun;51(6):795-6; author reply 796-7. doi: 10.1016/j.annemergmed.2007.11.043.
8
Drug-drug interactions among elderly patients hospitalized for drug toxicity.因药物毒性住院的老年患者中的药物相互作用。
JAMA. 2003 Apr 2;289(13):1652-8. doi: 10.1001/jama.289.13.1652.
9
Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.治疗2型糖尿病的口服药物:药理学、毒性及治疗
Ann Emerg Med. 2001 Jul;38(1):68-78. doi: 10.1067/mem.2001.114314.
10
Octreotide: an antidote for sulfonylurea-induced hypoglycemia.奥曲肽:磺酰脲类药物所致低血糖的一种解药。
Ann Emerg Med. 2000 Aug;36(2):133-138. doi: 10.1067/mem.2000.108183.